City Research Online

Items where City Author is "Long, Maria"

Up a level
Group by: Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Moncrieff, J., Crellin, N., Stansfeld, J. , Cooper, R., Marston, L., Freemantle, N., Lewis, G., Hunter, R., Johnson, S., Barnes, T., Morant, N., Pinfold, V., Smith, R., Kent, L., Darton, K., Long, M. ORCID: 0000-0002-6920-9676, Horowitz, M., Horne, R., Vickerstaff, V., Jha, M. & Priebe, S. (2023). Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial. The Lancet Psychiatry, 10(11), pp. 848-859. doi: 10.1016/s2215-0366(23)00258-4

Morant, N., Long, M. ORCID: 0000-0002-6920-9676, Jayacodi, S. , Cooper, R., Akther-Robertson, J., Stansfeld, J., Horowitz, M., Priebe, S. & Moncrieff, J. (2023). Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial. eClinicalMedicine, 64, article number 102135. doi: 10.1016/j.eclinm.2023.102135

Ramsay, G., Haime, Z., Crellin, N. E. , Stansfeld, J. L., Priebe, S., Long, M. ORCID: 0000-0002-6920-9676 & Moncrieff, J. (2023). Recruitment to a trial of antipsychotic reduction: impact of an acceptability study. BMC Medical Research Methodology, 23(1), article number 78. doi: 10.1186/s12874-023-01881-0

Long, M. ORCID: 0000-0002-6920-9676, Stansfeld, J. L., Davies, N. , Crellin, N. E. & Moncrieff, J. (2022). A systematic review of social functioning outcome measures in schizophrenia with a focus on suitability for intervention research. Schizophrenia Research, 241, pp. 275-291. doi: 10.1016/j.schres.2022.02.011

Crellin, N. E., Priebe, S., Morant, N. , Lewis, G., Freemantle, N., Johnson, S., Horne, R., Pinfold, V., Kent, L., Smith, R., Darton, K., Cooper, R. E., Long, M. ORCID: 0000-0002-6920-9676, Thompson, J., Gruenwald, L., Freudenthal, R., Stansfeld, J. L. & Moncrieff, J. (2022). An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders. BMC Psychiatry, 22(1), article number 185. doi: 10.1186/s12888-022-03822-5

This list was generated on Sat Oct 12 02:33:02 2024 UTC.